InflaRx N.V. IFRX
1.89
(0.04)
(2.07%)
as of 25 Sep
- Market cap
- $284.4M
- P/E
- 0.0×
Follow IFRX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
— | — | 2,220.94 | 440.26 | |
P/FCF ratio |
— | — | 0.00 | 0.00 | |
P/Operating CF |
— | — | (16.27) | (8.04) | |
P/B ratio |
— | — | 1.45 | 1.71 | |
Price to Tangible BV |
— | — | 1.45 | 1.71 | |
EV/Sales |
— | — | 411.26 | 150.90 | |
EV/EBITDA |
— | — | 0.00 | 0.00 | |
EV/Operating CF |
— | — | (0.31) | (0.65) | |
EV/FCF |
— | — | (0.31) | (0.64) | |
Quick Ratio |
8.10 | 3.88 | 3.88 | 2.78 | |
Current Ratio |
8.22 | 4.16 | 4.13 | 3.33 | |
Net Debt/EBITDA |
22.35 | 5.77 | 3.28 | 5.15 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.24 | 1.32 | 0.34 | 0.79 | |
Capex/Depreciation |
(0.50) | (0.11) | 0.02 | (0.83) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | (15,830.20%) | 26,146.59% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | (10,522.34%) | 15,871.68% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | (349.24%) | 2,929.75% | |
Graham Net Nets |
— | — | 0.67 | 0.56 | |
Graham Number |
— | — | 0.00 | 0.00 | |
Earnings Yield |
— | — | (75.25%) | (50.75%) | |
Free Cash Flow Yield |
— | — | (59.16%) | (53.18%) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.02) | (0.12) | (0.06) | (0.17) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.03) | (0.12) | (0.06) | (0.17) | |
Cash per Share |
1.60 | 0.69 | 0.82 | 0.88 | |
Shareholders Equity per Share |
1.44 | 0.60 | 0.70 | 0.78 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.44 | 0.60 | 0.70 | 0.78 | |
Free Cash Flow |
(2.99) | (8.66) | (4.17) | (11.40) | |
Working Capital |
168.90 | 42.14 | 45.99 | 51.92 | |
Capital Expenditures |
(0.05) | (0.01) | 0.00 | (0.10) | |
Net Current Asset Value |
168.21 | 41.43 | 45.23 | 51.05 | |
EV/EBIT |
— | — | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.05 | 3.72 | |
Net Profit Margin |
0.00% | 0.00% | 30,898.22% | (51,369.18%) | |
Price to Operating Income |
— | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1.90 | 1.86 | 1.75 | 2.41 | |
Average Payables |
8.61 | 7.24 | 9.22 | 11.84 | |
Average Inventory |
— | — | — | 8.31 | |
Average Assets |
138.72 | 74.44 | 72.37 | 81.89 | |
Average Common Equity |
117.36 | 58.71 | 56.74 | 62.41 |
Columns are period end dates